Elisabetta Perrone, MD, is a Nuclear Medicine Physician at Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome (Italy). Her clinical and research activity focuses on theranostics and novel radiopharmaceuticals (e.g., SSTR antagonists and Actinium-225-labelled compounds), with particular expertise in radioligand therapy of neuroendocrine neoplasms and prostate cancer, as well as FAP-based approaches. She also serves as ICPO Imaging Database Manager and E-Learning Specialist, and is a member of Theranostics and High-grade NEN G3 ENETS Task Forces.
